/Danaher%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Based in Washington, the District of Columbia, Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, industrial, and commercial products and services. Valued at $177.21 billion by market cap, the company offers a wide range of testing instruments, reagents and mass spectrometry, life science research tools, professional microscopes, filtration and flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization businesses. The life sciences and diagnostics innovator is expected to announce its fiscal second-quarter earnings for 2024 before the market opens on Tuesday, July 23.
Ahead of the event, analysts expect DHR to report a profit of $1.58 per share on a diluted basis, down 22.9% from $2.05 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.